7K6E

SARS-CoV-2 Main Protease Co-Crystal Structure with Telaprevir Determined from Crystals Grown with 40 nL Acoustically Ejected Mpro Droplets at 1.63 A Resolution (Direct Vitrification)

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2020-09-30	Initial release
1.1	2020-10-14		Author supporting evidence, Structure summary	pdbx_audit_support, pdbx_molecule_features
1.2	2021-01-27		Structure summary	entity, entity_name_com
1.3	2022-07-27		Author supporting evidence, Database references	citation, citation_author, database_2, pdbx_audit_support
1.4	2023-10-18		Data collection, Refinement description	chem_comp_atom, chem_comp_bond, pdbx_initial_refinement_model
1.5	2024-10-09		Structure summary	pdbx_entry_details, pdbx_modification_feature	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.